|
1
|
Warnakulasuriya S: Global epidemiology of
oral and oropharyngeal cancer. Oral Oncol. 45:309–316. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hoffman HT, Porter K, Karnell LH, Cooper
JS, Weber RS, Langer CJ, Ang KK, Gay G, Stewart A and Robinson RA:
Laryngeal cancer in the United States: Changes in demographics,
patterns of care, and survival. Laryngoscope. 116:1–13. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bayoumi AS, Sayed A, Broskova Z, Teoh JP,
Wilson J, Su H, Tang YL and Kim IM: Crosstalk between long
noncoding RNAs and microRNAs in health and disease. Int J Mol Sci.
17:3562016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gregory RI and Shiekhattar R: MicroRNA
biogenesis and cancer. Cancer Res. 65:3509–3512. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li J, Tian H, Yang J and Gong Z: Long
noncoding RNAs regulate cell growth, proliferation, and apoptosis.
DNA Cell Biol. 35:459–470. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shenouda SK and Alahari SK: MicroRNA
function in cancer: Oncogene or a tumor suppressor? Cancer
Metastasis Rev. 28:369–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li Y, Li Y, Chen W, He F, Tan Z, Zheng J,
Wang W, Zhao Q and Li J: NEAT expression is associated with tumor
recurrence and unfavorable prognosis in colorectal cancer.
Oncotarget. 6:27641–27650. 2015.PubMed/NCBI
|
|
9
|
Wu Y, Yang L, Zhao J, Li C, Nie J, Liu F,
Zhuo C, Zheng Y, Li B, Wang Z and Xu Y: Nuclear-enriched abundant
transcript 1 as a diagnostic and prognostic biomarker in colorectal
cancer. Mol Cancer. 14:1912015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen X, Kong J, Ma Z, Gao S and Feng X: Up
regulation of the long non-coding RNA NEAT1 promotes esophageal
squamous cell carcinoma cell progression and correlates with poor
prognosis. Am J Cancer Res. 5:2808–2815. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chakravarty D, Sboner A, Nair SS,
Giannopoulou E, Li R, Hennig S, Mosquera JM, Pauwels J, Park K,
Kossai M, et al: The oestrogen receptor alpha-regulated lncRNA
NEAT1 is a critical modulator of prostate cancer. Nat Commun.
5:53832014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun C, Li S, Zhang F, Xi Y, Wang L, Bi Y
and Li D: Long non-coding RNA NEAT1 promotes non-small cell lung
cancer progression through regulation of miR-377-3p-E2F3 pathway.
Oncotarget. 7:51784–51814. 2016.PubMed/NCBI
|
|
13
|
Lo PK, Zhang Y, Wolfson B, Gernapudi R,
Yao Y, Duru N and Zhou Q: Dysregulation of the BRCA1/long
non-coding RNA NEAT1 signaling axis contributes to breast
tumorigenesis. Oncotarget. 7:65067–65089. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cao J, Zhang Y, Yang J, He S, Li M, Yan S,
Chen Y, Qu C and Xu L: NEAT1 regulates pancreatic cancer cell
growth, invasion and migration though mircroRNA-335-5p/c-met axis.
Am J Cancer Res. 6:2361–2374. 2016.PubMed/NCBI
|
|
15
|
Yang X, Xiao Z, Du X, Huang L and Du G:
Silencing of the long non-coding RNA NEAT1 suppresses glioma
stem-like properties through modulation of the miR-107/CDK6
pathway. Oncol Rep. 37:555–562. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qian K, Liu G, Tang Z, Hu Y, Fang Y, Chen
Z and Xu X: The long non-coding RNA NEAT1 interacted with miR-101
modulates breast cancer growth by targeting EZH2. Arch Biochem
Biophys. 615:1–9. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nie J, Liu L, Zheng W, Chen L, Wu X, Xu Y,
Du X and Han W: microRNA-365, down-regulated in colon cancer,
inhibits cell cycle progression and promotes apoptosis of colon
cancer cells by probably targeting cyclin D1 and Bcl-2.
Carcinogenesis. 33:220–225. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kang SM, Lee HJ and Cho JY: MicroRNA-365
regulates NKX2-1, a key mediator of lung cancer. Cancer Lett.
335:487–494. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo SL, Ye H, Teng Y, Wang YL, Yang G, Li
XB, Zhang C and Yang X, Yang ZZ and Yang X: Akt-p53-miR-365-cyclin
D1/cdc25A axis contributes to gastric tumorigenesis induced by PTEN
deficiency. Nat Commun. 4:25442013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chandra Gupta S and Nandan Tripathi Y:
Potential of long non-coding RNAs in cancer patients: From
biomarkers to therapeutic targets. Int J Cancer. 140:1955–1967.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guo S, Chen W, Luo Y, Ren F, Zhong T, Rong
M, Dang Y, Feng Z and Chen G: Clinical implication of long
non-coding RNA NEAT1 expression in hepatocellular carcinoma
patients. Int J Clin Exp Pathol. 8:5395–5402. 2015.PubMed/NCBI
|
|
22
|
He C, Jiang B, Ma J and Li Q: Aberrant
NEAT1 expression is associated with clinical outcome in high grade
glioma patients. APMIS. 124:169–174. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gong W, Zheng J, Liu X, Ma J, Liu Y and
Xue Y: Knockdown of NEAT1 restrained the malignant progression of
glioma stem cells by activating microRNA let-7e. Oncotarget.
7:62208–62223. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li JH, Zhang SQ, Qiu XG, Zhang SJ, Zheng
SH and Zhang DH: Long non-coding RNA NEAT1 promotes malignant
progression of thyroid carcinoma by regulating miRNA-214. Int J
Oncol. 50:708–716. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jen J, Tang YA, Lu YH, Lin CC, Lai WW and
Wang YC: Oct4 transcriptionally regulates the expression of long
non-coding RNAs NEAT1 and MALAT1 to promote lung cancer
progression. Mol Cancer. 16:1042017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang P, Wu T, Zhou H, Jin Q, He G, Yu H,
Xuan L, Wang X, Tian L, Sun Y, et al: Long noncoding RNA NEAT1
promotes laryngeal squamous cell cancer through regulating
miR-107/CDK6 pathway. J Exp Clin Cancer Res. 35:222016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jiang P, Wu X, Wang X, Huang W and Feng Q:
NEAT1 upregulates EGCG-induced CTR1 to enhance cisplatin
sensitivity in lung cancer cells. Oncotarget. 7:43337–43351.
2016.PubMed/NCBI
|
|
28
|
Huang B, Liu C, Wu Q, Zhang J, Min Q,
Sheng T, Wang X and Zou Y: Long non-coding RNA NEAT1 facilitates
pancreatic cancer progression through negative modulation of
miR-506-3p. Biochem Biophys Res Commun. 482:828–834. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang Y, Xu C, Wang Y and Zhang X:
MicroRNA-365 inhibits ovarian cancer progression by targeting
Wnt5a. Am J Cancer Res. 7:1096–1106. 2017.PubMed/NCBI
|
|
30
|
Zhou M, Zhou L, Zheng L, Guo L, Wang Y,
Liu H, Ou C and Ding Z: miR-365 promotes cutaneous squamous cell
carcinoma (CSCC) through targeting nuclear factor I/B (NFIB). PLoS
One. 9:e1006202014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu Y, Zhang W, Liu S, Liu K, Ji B and
Wang Y: miR-365 targets ADAM10 and suppresses the cell growth and
metastasis of hepatocellular carcinoma. Oncol Rep. 37:1857–1864.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Riker AI, Enkemann SA, Fodstad O, Liu S,
Ren S, Morris C, Xi Y, Howell P, Metge B, Samant RS, et al: The
gene expression profiles of primary and metastatic melanoma yields
a transition point of tumor progression and metastasis. BMC Med
Genomics. 1:132008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li Q, Jin W, Cai Y, Yang F, Chen E, Ye D,
Wang Q and Guan X: Regulator of G protein signaling 20 correlates
with clinicopathological features and prognosis in triple-negative
breast cancer. Biochem Biophys Res Commun. 485:693–697. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang L, Lee MM, Leung MM and Wong YH:
Regulator of G protein signaling 20 enhances cancer cell
aggregation, migration, invasion and adhesion. Cell Signal.
28:1663–1672. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fu JW, Kong Y and Sun X: Long noncoding
RNA NEAT1 is an unfavorable prognostic factor and regulates
migration and invasion in gastric cancer. J Cancer Res Clin Oncol.
142:1571–1579. 2016. View Article : Google Scholar : PubMed/NCBI
|
